Student or educator? Sign up with your school email and get 6 months of Pro free.
Cited by 404

The DOI matches its Crossref record; 27 of the 27 references it cites were found in a registry or an index.

Is it time to reassess the BDNF hypothesis of depression?

Groves, J O·2007·Molecular Psychiatry

Overview

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1038/sj.mp.4002075

Cites

27 of 27 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 27 references

Research works printed but not linked: 79

  1. Hindmarch I . Beyond the monoamine hypothesis: mechanisms, molecules and methods. Eur Psychiatry 2002; 17 (Suppl 3): 294–299. · DOI
  2. Nestler EJ, Barrot M, DiLeone RJ, Eisch AJ, Gold SJ, Monteggia LM . Neurobiology of depression. Neuron 2002; 34: 13–25. · DOI · Paper page
  3. Thoenen H . Neurotrophins and neuronal plasticity. Science 1995; 270: 593–598. · DOI · Paper page
  4. Kafitz KW, Rose CR, Thoenen H, Konnerth A . Neurotrophin-evoked rapid excitation through TrkB receptors. Nature 1999; 401: 918–921. · DOI · Paper page
  5. McEwen BS . The neurobiology of stress: from serendipity to clinical relevance. Brain Res 2000; 886: 172–189. · DOI · Paper page
  6. Duman RS . Depression: a case of neuronal life and death? Biol Psychiatry 2004; 56: 140–145. · DOI · Paper page
  7. Duman RS . Neurotrophic factors and regulation of mood: role of exercise, diet and metabolism. Neurobiol Aging 2005; 26 (Suppl 1): 88–93. · DOI · Paper page
  8. Gross CG . Neurogenesis in the adult brain: death of a dogma. Nat Rev Neurosci 2000; 1: 67–73. · DOI · Paper page
  9. Dranovsky A, Hen R . Hippocampal neurogenesis: regulation by stress and antidepressants. Biol Psychiatry 2006; 59: 1136–1143. · DOI · Paper page
  10. Ibanez CF . Neurotrophic factors: from structure–function studies to designing effective therapeutics. Trends Biotechnol 1995; 13: 217–227. · DOI
  11. Fossati P, Radtchenko A, Boyer P . Neuroplasticity: from MRI to depressive symptoms. Eur Neuropsychopharmacol 2004; 14 (Suppl 5): S503–S510. · DOI
  12. Yuan J, Yankner BA . Apoptosis in the nervous system. Nature 2000; 407: 802–809. · DOI · Paper page
  13. Huang EJ, Reichardt LF . Neurotrophins: roles in neuronal development and function. Annu Rev Neurosci 2001; 24: 677–736. · DOI · Paper page
  14. Almeida RD, Manadas BJ, Melo CV, Gomes JR, Mendes CS, Graos MM et al. Neuroprotection by BDNF against glutamate-induced apoptotic cell death is mediated by ERK and PI3-kinase pathways. Cell Death Differ 2005; 12: 1329–1343. · DOI · Paper page
  15. Smith MA, Makino S, Kvetnansky R, Post RM . Effects of stress on neurotrophic factor expression in the rat brain. Ann NY Acad Sci 1995; 771: 234–239. · DOI · Paper page
  16. Vaidya VA, Marek GJ, Aghajanian GK, Duman RS . 5-HT2A receptor-mediated regulation of brain-derived neurotrophic factor mRNA in the hippocampus and the neocortex. J Neurosci 1997; 17: 2785–2795. · DOI · Paper page
  17. Ueyama T, Kawai Y, Nemoto K, Sekimoto M, Tone S, Senba E . Immobilization stress reduced the expression of neurotrophins and their receptors in the rat brain. Neurosci Res 1997; 28: 103–110. · DOI · Paper page
  18. Pizarro JM, Lumley LA, Medina W, Robison CL, Chang WE, Alagappan A et al. Acute social defeat reduces neurotrophin expression in brain cortical and subcortical areas in mice. Brain Res 2004; 1025: 10–20. · DOI · Paper page
  19. Rasmusson AM, Shi L, Duman R . Downregulation of BDNF mRNA in the hippocampal dentate gyrus after re-exposure to cues previously associated with footshock. Neuropsychopharmacology 2002; 27: 133–142. · DOI · Paper page
  20. Roceri M, Hendriks W, Racagni G, Ellenbroek BA, Riva MA . Early maternal deprivation reduces the expression of BDNF and NMDA receptor subunits in rat hippocampus. Mol Psychiatry 2002; 7: 609–616. · DOI · Paper page
  21. Siuciak JA, Lewis DR, Wiegand SJ, Lindsay RM . Antidepressant-like effect of brain-derived neurotrophic factor (BDNF). Pharmacol Biochem Behav 1997; 56: 131–137. · DOI · Paper page
  22. Shirayama Y, Chen AC, Nakagawa S, Russell DS, Duman RS . Brain-derived neurotrophic factor produces antidepressant effects in behavioral models of depression. J Neurosci 2002; 22: 3251–3261. · DOI · Paper page
  23. Nibuya M, Nestler EJ, Duman RS . Chronic antidepressant administration increases the expression of cAMP response element binding protein (CREB) in rat hippocampus. J Neurosci 1996; 16: 2365–2372. · DOI · Paper page
  24. Russo-Neustadt A, Beard RC, Cotman CW . Exercise, antidepressant medications, and enhanced brain derived neurotrophic factor expression. Neuropsychopharmacology 1999; 21: 679–682. · DOI · Paper page
  25. Coppell AL, Pei Q, Zetterstrom TS . Bi-phasic change in BDNF gene expression following antidepressant drug treatment. Neuropharmacology 2003; 44: 903–910. · DOI · Paper page
  26. Garza AA, Ha TG, Garcia C, Chen MJ, Russo-Neustadt AA . Exercise, antidepressant treatment, and BDNF mRNA expression in the aging brain. Pharmacol Biochem Behav 2004; 77: 209–220. · DOI
  27. Vinet J, Carra S, Blom JM, Brunello N, Barden N, Tascedda F . Chronic treatment with desipramine and fluoxetine modulate BDNF, CaMKKalpha and CaMKKbeta mRNA levels in the hippocampus of transgenic mice expressing antisense RNA against the glucocorticoid receptor. Neuropharmacology 2004; 47: 1062–1069. · DOI
  28. Smith MA, Zhang LX, Lyons WE, Mamounas LA . Anterograde transport of endogenous brain-derived neurotrophic factor in hippocampal mossy fibers. NeuroReport 1997; 8: 1829–1834. · DOI
  29. Newton SS, Collier EF, Hunsberger J, Adams D, Terwilliger R, Selvanayagam E et al. Gene profile of electroconvulsive seizures: induction of neurotrophic and angiogenic factors. J Neurosci 2003; 23: 10841–10851. · DOI · Paper page
  30. Altar CA, Laeng P, Jurata LW, Brockman JA, Lemire A, Bullard J et al. Electroconvulsive seizures regulate gene expression of distinct neurotrophic signaling pathways. J Neurosci 2004; 24: 2667–2677. · DOI · Paper page
  31. Neeper SA, Gomez-Pinilla F, Choi J, Cotman CW . Physical activity increases mRNA for brain-derived neurotrophic factor and nerve growth factor in rat brain. Brain Res 1996; 726: 49–56. · DOI · Paper page
  32. Adlard PA, Perreau VM, Engesser-Cesar C, Cotman CW . The timecourse of induction of brain-derived neurotrophic factor mRNA and protein in the rat hippocampus following voluntary exercise. Neurosci Lett 2004; 363: 43–48. · DOI · Paper page
  33. Russo-Neustadt AA, Alejandre H, Garcia C, Ivy AS, Chen MJ . Hippocampal brain-derived neurotrophic factor expression following treatment with reboxetine, citalopram, and physical exercise. Neuropsychopharmacology 2004; 29: 2189–2199. · DOI · Paper page
  34. Lauterborn JC, Truong GS, Baudry M, Bi X, Lynch G, Gall CM . Chronic elevation of brain-derived neurotrophic factor by ampakines. J Pharmacol Exp Ther 2003; 307: 297–305. · DOI
  35. Marvanova M, Lakso M, Pirhonen J, Nawa H, Wong G, Castren E . The neuroprotective agent memantine induces brain-derived neurotrophic factor and trkB receptor expression in rat brain. Mol Cell Neurosci 2001; 18: 247–258. · DOI
  36. Chen B, Dowlatshahi D, MacQueen GM, Wang JF, Young LT . Increased hippocampal BDNF immunoreactivity in subjects treated with antidepressant medication. Biol Psychiatry 2001; 50: 260–265. · DOI · Paper page
  37. Karege F, Bondolfi G, Gervasoni N, Schwald M, Aubry JM, Bertschy G . Low brain-derived neurotrophic factor (BDNF) levels in serum of depressed patients probably results from lowered platelet BDNF release unrelated to platelet reactivity. Biol Psychiatry 2005; 57: 1068–1072. · DOI · Paper page
  38. Aydemir O, Deveci A, Taneli F . The effect of chronic antidepressant treatment on serum brain-derived neurotrophic factor levels in depressed patients: a preliminary study. Prog Neuropsychopharmacol Biol Psychiatry 2005; 29: 261–265. · DOI · Paper page
  39. Gervasoni N, Aubry JM, Bondolfi G, Osiek C, Schwald M, Bertschy G et al. Partial normalization of serum brain-derived neurotrophic factor in remitted patients after a major depressive episode. Neuropsychobiology 2005; 51: 234–238. · DOI · Paper page
  40. Miro X, Perez-Torres S, Artigas F, Puigdomenech P, Palacios JM, Mengod G . Regulation of cAMP phosphodiesterase mRNAs expression in rat brain by acute and chronic fluoxetine treatment. An in situ hybridization study. Neuropharmacology 2002; 43: 1148–1157. · DOI
  41. Branchi I, D’Andrea I, Sietzema J, Fiore M, Di Fausto V, Aloe L et al. Early social enrichment augments adult hippocampal BDNF levels and survival of BrdU-positive cells while increasing anxiety- and ‘depression’-like behavior. J Neurosci Res 2006; 83: 965–973. · DOI
  42. Eisch AJ, Bolanos CA, de Wit J, Simonak RD, Pudiak CM, Barrot M et al. Brain-derived neurotrophic factor in the ventral midbrain-nucleus accumbens pathway: a role in depression. Biol Psychiatry 2003; 54: 994–1005. · DOI · Paper page
  43. Kalueff AV, Avgustinovich DF, Kudryavtseva NN, Murphy DL . BDNF in anxiety and depression. Science 2006; 312: 1598–1599; author reply. · DOI
  44. Liu QR, Lu L, Zhu XG, Gong JP, Shaham Y, Uhl GR . Rodent BDNF genes, novel promoters, novel splice variants, and regulation by cocaine. Brain Res 2006; 1067: 1–12. · DOI · Paper page
  45. MacQueen GM, Ramakrishnan K, Croll SD, Siuciak JA, Yu G, Young LT et al. Performance of heterozygous brain-derived neurotrophic factor knockout mice on behavioral analogues of anxiety, nociception, and depression. Behav Neurosci 2001; 115: 1145–1153. · DOI · Paper page
  46. Saarelainen T, Hendolin P, Lucas G, Koponen E, Sairanen M, MacDonald E et al. Activation of the TrkB neurotrophin receptor is induced by antidepressant drugs and is required for antidepressant-induced behavioral effects. J Neurosci 2003; 23: 349–357. · DOI · Paper page
  47. Chourbaji S, Hellweg R, Brandis D, Zorner B, Zacher C, Lang UE et al. Mice with reduced brain-derived neurotrophic factor expression show decreased choline acetyltransferase activity, but regular brain monoamine levels and unaltered emotional behavior. Brain Res Mol Brain Res 2004; 121: 28–36. · DOI · Paper page
  48. Rios M, Fan G, Fekete C, Kelly J, Bates B, Kuehn R et al. Conditional deletion of brain-derived neurotrophic factor in the postnatal brain leads to obesity and hyperactivity. Mol Endocrinol 2001; 15: 1748–1757. · DOI · Paper page
  49. Crawley JN . Unusual behavioral phenotypes of inbred mouse strains. Trends Neurosci 1996; 19: 181–182; discussion 188–189. · DOI · Paper page
  50. Inui A . Transgenic study of energy homeostasis equation: implications and confounding influences. FASEB J 2000; 14: 2158–2170. · DOI
  51. Chan JP, Unger TJ, Byrnes J, Rios M . Examination of behavioral deficits triggered by targeting Bdnf in fetal or postnatal brains of mice. Neuroscience 2006; 142: 49–58. · DOI
  52. Kendler KS, Kuhn J, Prescott CA . The interrelationship of neuroticism, sex, and stressful life events in the prediction of episodes of major depression. Am J Psychiatry 2004; 161: 631–636. · DOI · Paper page
  53. Zorner B, Wolfer DP, Brandis D, Kretz O, Zacher C, Madani R et al. Forebrain-specific trkB-receptor knockout mice: behaviorally more hyperactive than ‘depressive’. Biol Psychiatry 2003; 54: 972–982. · DOI
  54. Duman CH, Schlesinger L, Kodama M, Russell DS, Duman RS . A role for MAP kinase signaling in behavioral models of depression and antidepressant treatment. Biol Psychiatry 2007; 61: 661–670. · DOI · Paper page
  55. Dulawa SC, Hen R . Recent advances in animal models of chronic antidepressant effects: the novelty-induced hypophagia test. Neurosci Biobehav Rev 2005; 29: 771–783. · DOI · Paper page
  56. Govindarajan A, Rao BS, Nair D, Trinh M, Mawjee N, Tonegawa S et al. Transgenic brain-derived neurotrophic factor expression causes both anxiogenic and antidepressant effects. Proc Natl Acad Sci USA 2006; 103: 13208–13213. · DOI · Paper page
  57. Fava M, Kendler KS . Major depressive disorder. Neuron 2000; 28: 335–341. · DOI · Paper page
  58. Nash MW, Huezo-Diaz P, Williamson RJ, Sterne A, Purcell S, Hoda F et al. Genome-wide linkage analysis of a composite index of neuroticism and mood-related scales in extreme selected sibships. Hum Mol Genet 2004; 13: 2173–2182. · DOI
  59. Fullerton J, Cubin M, Tiwari H, Wang C, Bomhra A, Davidson S et al. Linkage analysis of extremely discordant and concordant sibling pairs identifies quantitative-trait loci that influence variation in the human personality trait neuroticism. Am J Hum Genet 2003; 72: 879–890. · DOI · Paper page
  60. Fanous A, Gardner CO, Prescott CA, Cancro R, Kendler KS . Neuroticism, major depression and gender: a population-based twin study. Psychol Med 2002; 32: 719–728. · DOI · Paper page
  61. Hettema JM, Neale MC, Myers JM, Prescott CA, Kendler KS . A population-based twin study of the relationship between neuroticism and internalizing disorders. Am J Psychiatry 2006; 163: 857–864. · DOI · Paper page
  62. Jang KL, Livesley WJ, Vernon PA . Heritability of the big five personality dimensions and their facets: a twin study. J Pers 1996; 64: 577–591. · DOI · Paper page
  63. Lake RI, Eaves LJ, Maes HH, Heath AC, Martin NG . Further evidence against the environmental transmission of individual differences in neuroticism from a collaborative study of 45 850 twins and relatives on two continents. Behav Genet 2000; 30: 223–233. · DOI · Paper page
  64. Lander ES, Schork NJ . Genetic dissection of complex traits. Science 1994; 265: 2037–2048. · DOI · Paper page
  65. Stoltenberg SF, Burmeister M . Recent progress in psychiatric genetics–some hope but no hype. Hum Mol Genet 2000; 9: 927–935. · DOI
  66. Duggan C, Sham P, Lee A, Minne C, Murray R . Neuroticism: a vulnerability marker for depression evidence from a family study. J Affect Disord 1995; 35: 139–143. · DOI
  67. Flint J . The genetic basis of neuroticism. Neurosci Biobehav Rev 2004; 28: 307–316. · DOI
  68. Sen S, Nesse RM, Stoltenberg SF, Li S, Gleiberman L, Chakravarti A et al. A BDNF coding variant is associated with the NEO personality inventory domain neuroticism, a risk factor for depression. Neuropsychopharmacology 2003; 28: 397–401. · DOI · Paper page
  69. Lang UE, Hellweg R, Kalus P, Bajbouj M, Lenzen KP, Sander T et al. Association of a functional BDNF polymorphism and anxiety-related personality traits. Psychopharmacology (Berl) 2005; 180: 95–99. · DOI · Paper page
  70. Hong CJ, Huo SJ, Yen FC, Tung CL, Pan GM, Tsai SJ . Association study of a brain-derived neurotrophic-factor genetic polymorphism and mood disorders, age of onset and suicidal behavior. Neuropsychobiology 2003; 48: 186–189. · DOI · Paper page
  71. Tsai SJ, Cheng CY, Yu YW, Chen TJ, Hong CJ . Association study of a brain-derived neurotrophic-factor genetic polymorphism and major depressive disorders, symptomatology, and antidepressant response. Am J Med Genet B Neuropsychiatr Genet 2003; 123: 19–22. · DOI · Paper page
  72. Choi MJ, Kang RH, Lim SW, Oh KS, Lee MS . Brain-derived neurotrophic factor gene polymorphism (Val66Met) and citalopram response in major depressive disorder. Brain Res 2006; 1118: 176–182. · DOI · Paper page
  73. Surtees PG, Wainwright NW, Willis-Owen SA, Sandhu MS, Luben R, Day NE et al. No association between the BDNF Val66Met polymorphism and mood status in a non-clinical community sample of 7389 older adults. J Psychiatr Res 2007; 41: 404–409. · DOI
  74. Willis-Owen SA, Fullerton J, Surtees PG, Wainwright NW, Miller S, Flint J . The Val66Met coding variant of the brain-derived neurotrophic factor (BDNF) gene does not contribute toward variation in the personality trait neuroticism. Biol Psychiatry 2005; 58: 738–742. · DOI
  75. Munafo MR, Clark T, Flint J . Does measurement instrument moderate the association between the serotonin transporter gene and anxiety-related personality traits. A meta-analysis. Mol Psychiatry 2005; 10: 415–419. · DOI · Paper page
  76. Chen ZY, Jing D, Bath KG, Ieraci A, Khan T, Siao CJ et al. Genetic variant BDNF (Val66Met) polymorphism alters anxiety-related behavior. Science 2006; 314: 140–143. · DOI · Paper page
  77. Jiang X, Xu K, Hoberman J, Tian F, Marko AJ, Waheed JF et al. BDNF variation and mood disorders: a novel functional promoter polymorphism and Val66Met are associated with anxiety but have opposing effects. Neuropsychopharmacology 2005; 30: 1353–1361. · DOI · Paper page
  78. Hwang JP, Tsai SJ, Hong CJ, Yang CH, Lirng JF, Yang YM . The Val66Met polymorphism of the brain-derived neurotrophic-factor gene is associated with geriatric depression. Neurobiol Aging 2006; 27: 1834–1837. · DOI · Paper page
  79. Nestler EJ, Carlezon Jr WA . The mesolimbic dopamine reward circuit in depression. Biol Psychiatry 2006; 59: 1151–1159. · DOI · Paper page

Cited by

See all 404

Metadata

Authors
Groves, J. O.
Venue
Molecular Psychiatry
Published
2007-08-14
Volume
12
Issue
12
Pages
1079-1088
ISSN
  • 1359-4184 (ISSN-L)
  • 1476-5578
OpenAlex
W2025311391
Cited by
404
References
27
FWCI
19.59
Type
journal article
Language
en
Open access
closed
Licence

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Is it time to reassess the BDNF hypothesis of depression? https://app.cochat.ai/papers/10.1038/sj.mp.4002075
The paper
Groves, J. O. (2007). Is it time to reassess the BDNF hypothesis of depression? Molecular Psychiatry. https://doi.org/10.1038/sj.mp.4002075

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.